Fairmont Hotel Vancouver Floorplan

Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2014
Here are the related meetings in 2021:
Obesity: From Cell to Patient (EK17)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Obesity: A Multisystems Perspective (J2)
Organizer(s) Roger D. Cone, Barbara Cannon and Lee M. Kaplan
January 12—17, 2014
Fairmont Hotel Vancouver • Vancouver, BC Canada
Discounted Abstract Deadline: Oct 4, 2013
Abstract Deadline: Oct 29, 2013
Scholarship Deadline: Oct 4, 2013
Discounted Registration Deadline: Nov 14, 2013
Supported by the Directors' Fund
Summary of Meeting:
This meeting will cover the latest discoveries on the role of multiple organ systems in the process of energy homeostasis and obesity. In addition to the role of the central nervous system and white adipose tissue (WAT) depots, this meeting will examine the role of WAT development, brown fat, the microbiome, gut-brain signaling and circadian rhythms in the development of obesity. Bariatric surgery and the latest pharmaceutical approaches to obesity treatment will also be considered, as will the latest genetic approaches to both common and rare syndromic obesity. Joint sessions with the Keystone Symposia meeting on Challenges and Opportunities in Diabetes Research and Treatment will include “The Role of Brown Adipose Tissue in Thermogenesis and Glucose Uptake” and “Mechanisms Underlying the Efficacy of Bariatric Surgery.” This meeting will bring together a diverse array of leading scientists from the U.S., Europe and Japan to talk about breaking discoveries in a very broad array of physiological processes relevant to obesity and its treatment. The goal of the meeting will be to provide participants with an update on cutting-edge developments in the field, as well as with a broader perspective on the biology of obesity. The anticipated outcome is the development of new, and potentially interdisciplinary, research collaborations and directions.
View Scholarships/Awards
This meeting will cover the latest discoveries on the role of multiple organ systems in the process of energy homeostasis and obesity. In addition to the role of the central nervous system and white adipose tissue (WAT) depots, this meeting will examine the role of WAT development, brown fat, the microbiome, gut-brain signaling and circadian rhythms in the development of obesity. Bariatric surgery and the latest pharmaceutical approaches to obesity treatment will also be considered, as will the latest genetic approaches to both common and rare syndromic obesity. Joint sessions with the Keystone Symposia meeting on Challenges and Opportunities in Diabetes Research and Treatment will include “The Role of Brown Adipose Tissue in Thermogenesis and Glucose Uptake” and “Mechanisms Underlying the Efficacy of Bariatric Surgery.” This meeting will bring together a diverse array of leading scientists from the U.S., Europe and Japan to talk about breaking discoveries in a very broad array of physiological processes relevant to obesity and its treatment. The goal of the meeting will be to provide participants with an update on cutting-edge developments in the field, as well as with a broader perspective on the biology of obesity. The anticipated outcome is the development of new, and potentially interdisciplinary, research collaborations and directions.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
SUNDAY, JANUARY 12
MONDAY, JANUARY 13
TUESDAY, JANUARY 14
WEDNESDAY, JANUARY 15
THURSDAY, JANUARY 16
FRIDAY, JANUARY 17
Conference Program Print | View meeting in 12 hr (am/pm) time
SUNDAY, JANUARY 12
08:30—09:30
Keynote Session (Joint)
C. Ronald Kahn,
Joslin Diabetes Center and Harvard Medical School, USA
An Increasing Web of Interactions in Diabetes and Obesity
An Increasing Web of Interactions in Diabetes and Obesity
10:00—12:15
Development of Adipose Tissue
*
Christian Wolfrum,
ETH Zürich, Switzerland
Jonathan M. Graff,
University of Texas Southwestern Medical Center, USA
Adipose Stem Cells: Give Me a Pill Not a Treadmill
Adipose Stem Cells: Give Me a Pill Not a Treadmill
Peter Arner,
Karolinska Institutet, Sweden
Bone Marrow as a Source of Adipocytes in Adult Humans
Bone Marrow as a Source of Adipocytes in Adult Humans
David A. Guertin,
University of Massachusetts Medical School, USA
Short Talk: New Insights into the Origins and Programming of Adipocyte Development
Short Talk: New Insights into the Origins and Programming of Adipocyte Development
Dwight J. Klemm,
University of Colorado Denver Anschutz Medical Center, USA
Short Talk: De Novo Generation of Adipocytes from Bone Marrow in Human Adipose Tissue
Short Talk: De Novo Generation of Adipocytes from Bone Marrow in Human Adipose Tissue
10:00—12:30
Metabolic Control in Liver
*
Masato Kasuga,
National Center for Global Health and Medicine, Japan
Rebecca A. Haeusler,
Columbia University, USA
Regulation of Metabolic Flux by FoxOs during the Fasting–Refeeding Transition
Regulation of Metabolic Flux by FoxOs during the Fasting–Refeeding Transition
Morris J. Birnbaum,
Pfizer Inc., USA
The Control of Hepatic Metabolism by Insulin
The Control of Hepatic Metabolism by Insulin
Kei Sakamoto,
Nestlé Institute of Health Sciences, Switzerland
LKB1-SIK Signaling Pathway in the Control of Hepatic Gluconeogenesis
LKB1-SIK Signaling Pathway in the Control of Hepatic Gluconeogenesis
David J. Lloyd,
Amgen, Inc., USA
Short Talk: Small Molecule Disruption of the GKRP-GK Interaction Accompanied with Glucose Lowering Efficacy
Short Talk: Small Molecule Disruption of the GKRP-GK Interaction Accompanied with Glucose Lowering Efficacy
Hans-Ulrich Häring,
Eberhard-Karls University Tübingen, Germany
Subphenotypes in Prediabetes: Role of Fatty Liver and Brain Insulin Resistance
Subphenotypes in Prediabetes: Role of Fatty Liver and Brain Insulin Resistance
14:30—16:30
Workshop 1: Obesity Drug Discovery
*
Minmin Wang,
Eli Lilly and Company, USA
Lex H.T. Van der Ploeg,
VDP LLC, USA
Melanocortin 4 Receptor Agonists for the Treatment of Obesity
Melanocortin 4 Receptor Agonists for the Treatment of Obesity
David Maggs,
Fractyl Labs, USA
Endobarrier Therapy for Obesity and Diabetes
Endobarrier Therapy for Obesity and Diabetes
Lotte Bjerre Knudsen,
Novo Nordisk A/S, Denmark
Liraglutide Lowers Body Weight through CART, NPY and AgRP
Liraglutide Lowers Body Weight through CART, NPY and AgRP
Yong Xu,
Baylor College of Medicine, USA
Targeting Hypothalamic Steroid Receptor Co-Activator-1 to Treat Diet-Induced Obesity
Targeting Hypothalamic Steroid Receptor Co-Activator-1 to Treat Diet-Induced Obesity
Zachary R. Patterson,
Carleton University, Canada
Novel GOAT Inhibitor, CF801, Reduces Acylated Ghrelin and Body Weight in C57/BL6J Male Mice: A Potential Treatment for Obesity Related Disorders
Novel GOAT Inhibitor, CF801, Reduces Acylated Ghrelin and Body Weight in C57/BL6J Male Mice: A Potential Treatment for Obesity Related Disorders
Susan Cellitti,
Genomics Institute of the Novartis Research Foundation, USA
A Novel GLP-1-FGF21 Fusion Protein for the Treatment of Diabetes and Obesity
A Novel GLP-1-FGF21 Fusion Protein for the Treatment of Diabetes and Obesity
14:30—16:30
Workshop 1: Inflammation and Insulin Sensitivity
*
Anna Krook,
Karolinska Institutet, Sweden
Tine Hannibal,
University of Copenhagen, Denmark
Investigating the Role of Plasmacytoid Dendritic Cells in Inflammation Associated with Diabetes
Investigating the Role of Plasmacytoid Dendritic Cells in Inflammation Associated with Diabetes
Jan Mauer,
Max Planck Institute for Neurological Research, Germany
Novel Aspects of Macrophage IL-6-Signaling in Obesity-Associated Inflammation
Novel Aspects of Macrophage IL-6-Signaling in Obesity-Associated Inflammation
Tadasuke Komori,
Wakayama Medical University, Japan
Oncostatin M Protects against Obesity and Related Metabolic Disorders in Mice
Oncostatin M Protects against Obesity and Related Metabolic Disorders in Mice
Aurele Besse-Patin,
Montreal Neurological Institute, Canada
Loss of Pgc-1alpha Expression in Aging Mouse Muscle Potentiates Glucose Intolerance and Systemic Inflammation
Loss of Pgc-1alpha Expression in Aging Mouse Muscle Potentiates Glucose Intolerance and Systemic Inflammation
Yan-Shan Dai,
Central South University, China
NFATc3 Is Required for Pancreatic beta-Cell Function and Adipose Tissue Inflammation
NFATc3 Is Required for Pancreatic beta-Cell Function and Adipose Tissue Inflammation
Darren C. Henstridge,
Baker IDI Heart and Diabetes Institute, Australia
HSP72 Prevents Peripheral Tissue Lipotoxicity and Preserves Insulin Sensitivity by Increasing Oxidative Metabolism in Skeletal Muscle
HSP72 Prevents Peripheral Tissue Lipotoxicity and Preserves Insulin Sensitivity by Increasing Oxidative Metabolism in Skeletal Muscle
17:00—19:15
Role of Brown Adipose Tissue in Thermogenesis and Glucose Uptake (Joint)
*
Jan Nedergaard,
Stockholm University, Sweden
*
Alexander S. Banks,
Harvard Medical School, USA
Barbara Cannon,
Stockholm University, Sweden
Brown adipose tissue and thermogenesis
Brown adipose tissue and thermogenesis
Joerg Heeren,
University Medical Center Hamburg-Eppendorf, Germany
Brown Adipose Tissue and a Potential Role in Resolution of the Metabolic Syndrome
Brown Adipose Tissue and a Potential Role in Resolution of the Metabolic Syndrome
Masayuki Saito,
Tenshi College, Japan
Brown Adipose Tissue as a Regulator of Energy Expenditure and Body Fatness in Humans
Brown Adipose Tissue as a Regulator of Energy Expenditure and Body Fatness in Humans
08:30—11:45
Mechanisms Underlying the Efficacy of Bariatric Surgery (Joint)
*
C. Ronald Kahn,
Joslin Diabetes Center and Harvard Medical School, USA
*
Laurent Gautron,
University of Texas Southwestern Medical Center, USA
Lee M. Kaplan,
Massachusetts General Hospital, USA
Molecular Mechanisms of Response to Roux-en-Y Gastric Bypass
Molecular Mechanisms of Response to Roux-en-Y Gastric Bypass
Blandine Laferrère,
St. Luke's-Roosevelt, Columbia University, USA
Mechanism of Diabetes Remission after Gastric Bypass Surgery: Not Just Weight Loss
Mechanism of Diabetes Remission after Gastric Bypass Surgery: Not Just Weight Loss
Carel Le Roux,
University College Dublin, Ireland
Gastro Intestinal Regulation of Appetitive Drives
Gastro Intestinal Regulation of Appetitive Drives
Hans Rudolf Berthoud,
Pennington Biomedical Research Center, USA
Neural Mechanisms of Gastric Bypass
Neural Mechanisms of Gastric Bypass
Nicholas Stylopoulos,
Harvard Medical School and Boston Children's Hospital, USA
Short Talk: Bypassing Diabetes by Reprogramming Intestinal Metabolism
Short Talk: Bypassing Diabetes by Reprogramming Intestinal Metabolism
Thomas Alexander Lutz,
University of Zürich, Switzerland
Short Talk: GLP-1 Contributes to Improved Vascular Reactivity after Roux-en-Y Gastric Bypass Surgery (RYGB)
Short Talk: GLP-1 Contributes to Improved Vascular Reactivity after Roux-en-Y Gastric Bypass Surgery (RYGB)
14:30—16:30
Workshop 2: Hypothalamic Development and Maternal Effects
Kevin L. Grove,
Novo Nordisk, USA
Effects of Maternal Overnutrition
Effects of Maternal Overnutrition
Lori M. Zeltser,
Columbia University, USA
Early Intervention in a Mouse Model of Childhood Obesity
Early Intervention in a Mouse Model of Childhood Obesity
*
William F. Colmers,
University of Alberta, Canada
Talk Title Unknown
Talk Title Unknown
14:30—16:30
Workshop 2: Advances in the Diabetes Drug Pipeline
Avirup Bose,
Novartis Institutes for Biomedical Research Inc., USA
FGF21 Pharmacology: Implications for T2D and Beyond?
FGF21 Pharmacology: Implications for T2D and Beyond?
Philip J. Larsen,
Bayer Pharmaceuticals, Germany
Diabetes Therapy of Tomorrow: Beyond Glycemic Control
Diabetes Therapy of Tomorrow: Beyond Glycemic Control
Anish Konkar,
Eli Lilly and Company, Germany
Leveraging Gut Peptides for the Treatment of Type 2 Diabetes
Leveraging Gut Peptides for the Treatment of Type 2 Diabetes
*
Cristina M. Rondinone,
Cellarity Inc., USA
Biologics: The Future of Cardiometabolic Medicines?
Biologics: The Future of Cardiometabolic Medicines?
Alessandro Pocai,
Janssen, Pharmaceutical Companies of Johnson & Johnson, USA
Glucagon Agonism to Treat Diabetes
Glucagon Agonism to Treat Diabetes
Yoshiyuki Tsujihata,
Takeda Pharmaceutical Company, Ltd., Japan
Efficacy of Mono and Combination Therapy with GPR40/FFAR1 Agonist Fasiglifam in Animal Models Suggest Potential New Treatment for Type 2 Diabetes
Efficacy of Mono and Combination Therapy with GPR40/FFAR1 Agonist Fasiglifam in Animal Models Suggest Potential New Treatment for Type 2 Diabetes
*
Bei B. Zhang,
Pfizer Inc., USA
Challenges and Opportunities in Diabetes Drug Discovery
Challenges and Opportunities in Diabetes Drug Discovery
17:00—18:45
Role of the Gut Microbiota in Obesity and Metabolic Disorders
*
Helen Cox,
King's College London, UK
Frank J. Gonzalez,
National Institutes of Health, USA
Microbiome and Intestinal Farnesoid X Receptor in the Control of Obesity
Microbiome and Intestinal Farnesoid X Receptor in the Control of Obesity
Martin J. Blaser,
New York University School of Medicine, USA
Effects of Early Life Antibiotics on Developmental Phenotypes
Effects of Early Life Antibiotics on Developmental Phenotypes
Patrice D. Cani,
Université Catholique de Louvain, Belgium
Cross-Talks between Host Intestinal Epithelial Cells and Gut Microbes Controls Energy Homeostasis
Cross-Talks between Host Intestinal Epithelial Cells and Gut Microbes Controls Energy Homeostasis
17:00—18:45
Diabetes and Neurodegenerative Disorders
*
Morris F. White,
Boston Children's Hospital, Harvard Medical School, USA
IRS Signaling Balances Metabolic Homeostasis and Neurodegeneration
IRS Signaling Balances Metabolic Homeostasis and Neurodegeneration
Linda Partridge,
Max Planck Institute for Biology of Ageing, Germany
Nutrient-Sensing Pathways and Aging
Nutrient-Sensing Pathways and Aging
Ana Maria Cuervo,
Albert Einstein College of Medicine, USA
The Dual Function of Autophagy in Aging and Age-Related Disorders
The Dual Function of Autophagy in Aging and Age-Related Disorders
08:30—11:45
Genetics of Obesity and Metabolic Traits
*
Elizabeth K. Speliotes,
University of Michigan, USA
Struan F. A. Grant,
Children’s Hospital of Philadelphia Research Institute, USA
Genetics of Common Paediatric Obesity
Genetics of Common Paediatric Obesity
Cristen J. Willer,
University of Michigan, USA
Genetic Architecture of Obesity: Lessons Learned from Lipids
Genetic Architecture of Obesity: Lessons Learned from Lipids
Abhimanyu Garg,
University of Texas Southwestern Medical Center, USA
Genetic Basis of Lipodystrophies
Genetic Basis of Lipodystrophies
Marcelo Nobrega,
University of Chicago, USA
Short Talk: Obesity-Associated Variants within FTO Form Long-Range Functional Connections with IRX3
Short Talk: Obesity-Associated Variants within FTO Form Long-Range Functional Connections with IRX3
Christopher Lelliott,
Wellcome Trust Sanger Institute, UK
Short Talk: Discovery of Novel Genes Relevant for Metabolic Homeostasis by the Sanger Mouse Genetics Project
Short Talk: Discovery of Novel Genes Relevant for Metabolic Homeostasis by the Sanger Mouse Genetics Project
08:30—11:30
Nutrigenomics
*
Simeon Taylor,
University of Maryland School of Medicine, USA
Christopher B. Newgard,
Duke University Medical Center, USA
Intermediary Metabolism and Insulin Resistance
Intermediary Metabolism and Insulin Resistance
Murielle M. Veniant,
Amgen Inc., USA
FGF21, a Potential Therapeutic for Type 2 Diabetes
FGF21, a Potential Therapeutic for Type 2 Diabetes
Feifan Guo,
Institute for Nutritional Sciences, China
Branched Chain Amino Acids and Metabolic Signaling
Branched Chain Amino Acids and Metabolic Signaling
Wataru Ogawa,
Kobe University, Japan
Novel Variants of PGC1alpha and Muscle Energy Efficiency
Novel Variants of PGC1alpha and Muscle Energy Efficiency
Alexander S. Banks,
Harvard Medical School, USA
Short Talk: Both Erk and Cdk5 Kinases Control the Diabetogenic Actions of PPARgamma
Short Talk: Both Erk and Cdk5 Kinases Control the Diabetogenic Actions of PPARgamma
Christian Bjorbaek,
Beth Israel Deaconess Medical Center, USA
Short Talk: Hypothalamic AgRP Neurons and the Central Melanocortin System are Mediators of Leptin’s Anti-Diabetic Actions
Short Talk: Hypothalamic AgRP Neurons and the Central Melanocortin System are Mediators of Leptin’s Anti-Diabetic Actions
17:00—19:00
CNS Control of Energy Homeostasis
*
Jens C. Brüning,
Max Planck Institute for Metabolism Research, Germany
Scott M. Sternson,
HHMI/Janelia Research Campus, USA
Neural Circuits that Control Feeding Behavior
Neural Circuits that Control Feeding Behavior
Roger D. Cone,
University of Michigan, USA
Novel Allosteric Modulators and Signaling Modalities of the Melanocortin-4 Receptor
Novel Allosteric Modulators and Signaling Modalities of the Melanocortin-4 Receptor
Michael Rosenbaum,
Columbia University Medical College, USA
Leptin Depletion and Repletion
Leptin Depletion and Repletion
Peter K. Jackson,
Stanford University, USA
Short Talk: Neuropeptide Y Family Receptors Traffic via the Bardet-Biedl Syndromepathway to Signal in Neuronal Primary Cilia
Short Talk: Neuropeptide Y Family Receptors Traffic via the Bardet-Biedl Syndromepathway to Signal in Neuronal Primary Cilia
17:00—19:00
Insulin Sensitivity in the CV System
*
Juleen R. Zierath,
Karolinska Institutet, Sweden
Alan R. Tall,
Columbia University, USA
Diabetes and Obesity Promote Myelopoiesis and Atherogenesis
Diabetes and Obesity Promote Myelopoiesis and Atherogenesis
E. Dale Abel,
University of Iowa, Carver College of Medicine, USA
Myocardial Insulin Signaling, Hyperinsulinemia and Heart Failure
Myocardial Insulin Signaling, Hyperinsulinemia and Heart Failure
Sekar Kathiresan,
Verve Therapeutics, USA
Diabetes and Cardiovascular Disease: Is there a Causal Link in Humans?
Diabetes and Cardiovascular Disease: Is there a Causal Link in Humans?
In-Kyu Lee,
Kyungpook National University Hospital, South Korea
Short Talk: The Role of PDK4 in Vascular Calcification
Short Talk: The Role of PDK4 in Vascular Calcification
08:30—11:45
Circadian Rhythms, Obesity and Metabolic Disorders
Joseph T. Bass,
Northwestern University, USA
Circadian Integration of Mitochondrial Oxidative Function and Behavior
Circadian Integration of Mitochondrial Oxidative Function and Behavior
Eve Van Cauter,
University of Chicago, USA
Sleep Disturbances and Obesity
Sleep Disturbances and Obesity
*
Satchidananda Panda,
The Salk Institute for Biological Studies, USA
Rhythmic Feeding and Fasting Prevents Metabolic Diseases in Mice
Rhythmic Feeding and Fasting Prevents Metabolic Diseases in Mice
Joseph S. Takahashi,
HHMI/University of Texas Southwestern Medical Center, USA
Molecular Mechanisms of the Mammalian Circadian Clock
Molecular Mechanisms of the Mammalian Circadian Clock
Zach Gerhart-Hines,
University of Copenhagen, Denmark
Short Talk: The Nuclear Receptor Rev-erb? Controls Circadian Thermogenic Plasticity
Short Talk: The Nuclear Receptor Rev-erb? Controls Circadian Thermogenic Plasticity
Rosa van den Berg,
Leiden University Medical Center, Netherlands
Short Talk: Circadian Rhythm Modulates Body Fat Mass through Regulation of Brown Adipose Tissue Function
Short Talk: Circadian Rhythm Modulates Body Fat Mass through Regulation of Brown Adipose Tissue Function
08:30—11:30
Diabetes and Cancer
*
Lily Q. Dong,
University of Texas Health Science Center, USA
Derek Leroith,
Mount Sinai School of Medicine, USA
Diabetes and Cancer: The Role of Insulin and IGFs
Diabetes and Cancer: The Role of Insulin and IGFs
Timothy E. McGraw,
Weill Medical College of Cornell University, USA
Cancer Metabolism
Cancer Metabolism
Kathryn E. Wellen,
University of Pennsylvania, USA
Metabolic Reprogramming in Cancer Cells: Links to the Epigenome
Metabolic Reprogramming in Cancer Cells: Links to the Epigenome
Li Qiang,
Columbia University Medical Center, USA
Short Talk: Deficiency of Deleted in Breast Cancer 1 Increases Risks for Metabolic Disorders through Activation of Stearoyl-Coenzyme A Desaturase 1
Short Talk: Deficiency of Deleted in Breast Cancer 1 Increases Risks for Metabolic Disorders through Activation of Stearoyl-Coenzyme A Desaturase 1
11:45—12:30
Joint Workshop: NIH Funding Opportunities through NIDDK
Carol Renfrew Haft,
NIDDK, National Institutes of Health, USA
Aaron Pawlyk,
Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA
14:30—16:30
Workshop 3: Late Breaking Results
*
Lora K. Heisler,
Rowett Institute, University of Aberdeen, UK
Brian Finan,
Novo Nordisk, USA
Molecular Cold Mimicry via TRPM8 Modulation Amplifies Thermogenesis by Influencing the Adrenergic Axis
Molecular Cold Mimicry via TRPM8 Modulation Amplifies Thermogenesis by Influencing the Adrenergic Axis
Jayne F. Martin Carli,
Columbia University Medical Center, USA
Functional Analysis of Potential Modifiers of Leptin Production Identified by GWAS
Functional Analysis of Potential Modifiers of Leptin Production Identified by GWAS
Chen Liu,
University of Texas Southwestern Medical Center, USA
A Paradoxical Orexigenic 5HT2CR Circuit in Forebrain Sim1 Neurons
A Paradoxical Orexigenic 5HT2CR Circuit in Forebrain Sim1 Neurons
Joseph H. Nadeau,
Maine Medical Center Research Institute, USA
Fractal Genetics, Gene Interactions and Systems Properties of Diet Induced Metabolic Conditions
Fractal Genetics, Gene Interactions and Systems Properties of Diet Induced Metabolic Conditions
Maja Storm Engelstoft,
Kallyope, USA
Identical Nutrient Metabolite Sensors Stimulate GLP-1 Release and Inhibit Ghrelin Release through Differential, Cell-Specific G Protein Coupling
Identical Nutrient Metabolite Sensors Stimulate GLP-1 Release and Inhibit Ghrelin Release through Differential, Cell-Specific G Protein Coupling
Eugenia Morselli,
University of Texas Southwestern Medical Center, USA
Hypothalamic PGC-1alpha Protects against High Fat Diet Exposure by Regulating ER alpha
Hypothalamic PGC-1alpha Protects against High Fat Diet Exposure by Regulating ER alpha
Arian F. Baquero,
Novo Nordisk Inc., USA
ATP-Sensitive Potassium Channels (KATP) Are Essential for the Switch in Leptin Signaling to its Inhibitory Actions on NPY/AgRP Neurons during Development
ATP-Sensitive Potassium Channels (KATP) Are Essential for the Switch in Leptin Signaling to its Inhibitory Actions on NPY/AgRP Neurons during Development
17:00—19:15
All Kinds of -kines
*
Sheila Collins,
Vanderbilt University Medical Center, USA
Steven A. Kliewer,
University of Texas Southwestern Medical Center, USA
FGF21: From Feast to Famine to Pharmacology
FGF21: From Feast to Famine to Pharmacology
Ruth E. Gimeno,
Eli Lilly and Company, USA
Secreted Proteins as Therapeutic Targets for Metabolic Disorders
Secreted Proteins as Therapeutic Targets for Metabolic Disorders
Jaemyoung Suh,
Korea Advanced Institute of Science & Technology, South Korea
New Roles for FGF1 in Metabolic Homeostasis and Insulin Sensitization
New Roles for FGF1 in Metabolic Homeostasis and Insulin Sensitization
Rajesh R. Rao,
Genomics Institute of Novartis Research Foundation, USA
Short Talk: Identification of a Novel PGC-1alpha4-Dependent Myokine that Regulates Adipose Tissue Thermogenesis, Energy Homeostasis and Inflammation
Short Talk: Identification of a Novel PGC-1alpha4-Dependent Myokine that Regulates Adipose Tissue Thermogenesis, Energy Homeostasis and Inflammation
Nicholas Douris,
Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Short Talk: The Sympathetic Nervous System Mediates Systemic Adaptation to the Ketogenic Diet
Short Talk: The Sympathetic Nervous System Mediates Systemic Adaptation to the Ketogenic Diet
17:00—19:00
Approaches to Beta Cell Failure in Type 2 Diabetes
Susumu Seino,
Kobe University Graduate School of Medicine, Japan
Cell Signaling in Insulin Secretion: Novel Mechanisms of cAMP Action
Cell Signaling in Insulin Secretion: Novel Mechanisms of cAMP Action
Tsai-Hsiu Tess Lu,
Max-Planck Institute of Immunobiology and Epigenetics, Germany
Short Talk: PRC2 Stabilizes Functional Beta-Cell Transcriptional Program and Prevents Terminal Dedifferentiation
Short Talk: PRC2 Stabilizes Functional Beta-Cell Transcriptional Program and Prevents Terminal Dedifferentiation
*Session Chair †Invited, not yet responded.
We gratefully acknowledge support for this conference from:
We gratefully acknowledge the generous grant for this conference provided by:
We gratefully acknowledge additional support for this conference from:
![]() |
![]() |
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
![]() |
|
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Corporate Relations, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org, Phone:+1 970-262-1179 |